fda glp-1 compounding enforcement september 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers Did the FDA Ban Compounded

In the Wegovy-pill clinical trial, 18% of people who received the medication discontinued the treatment, which was less than the 26% rate in the placebo group

New GLP-1 medications on the horizon The GLP-1 receptor agonist space is evolving rapidly

Brand-name Ozempic MEDVi also offers brand-name Ozempic for patients who specifically want the FDA-approved product

Available from compounding pharmacies and medical supply retailers

Through the Zepbound self-pay program, tirzepatide is available directly to patients as a 4-count single-dose vial or single-patient-use KwikPen

Study characteristics A detailed overview of the study characteristics is presented in Table 2